| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2007 | WO2006127588A3 Modulators of atp-binding cassette transporters |
| 07/26/2007 | WO2006122154A3 Pyridone derivatives for modulating stress-activated protein kinase system |
| 07/26/2007 | WO2006121857A3 Unsolvated and host-guest solvated crystalline forms of (2e,4s)-4-[(n-{[(2r)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-l-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and their pharmaceutical uses |
| 07/26/2007 | WO2006116582A3 Pharmaceutical compositions comprising a substituted benzimidazole, buffering agent and vitamin b12 |
| 07/26/2007 | WO2006107853A3 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 07/26/2007 | WO2006102728A3 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases |
| 07/26/2007 | WO2006079625A3 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 07/26/2007 | WO2006065706A9 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 07/26/2007 | WO2006036711A3 Feature isolation for frequency-shifting interferometry |
| 07/26/2007 | WO2006034420A3 Multi-purpose bio-material composition |
| 07/26/2007 | WO2005120200A3 Amine compounds and inhibiting neurotransmitter reuptake |
| 07/26/2007 | WO2005105092A3 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070173913 Methods and devices for epithelial protection during photodynamic therapy |
| 07/26/2007 | US20070173784 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173547 Method for producing dry powders of one or several carotenoids |
| 07/26/2007 | US20070173546 Selective androgen receptor modulators and method of use thereof |
| 07/26/2007 | US20070173545 Activation of hypoxia-inducible gene expression |
| 07/26/2007 | US20070173544 Compounds for the treatment of metabolic disorders |
| 07/26/2007 | US20070173543 Synthesis of polycyclic procyanidins |
| 07/26/2007 | US20070173542 Peptide deformylase inhibitors |
| 07/26/2007 | US20070173541 DNT-succinate and methods of preparation thereof |
| 07/26/2007 | US20070173540 DNT-benzenesulfonate and methods of preparation thereof |
| 07/26/2007 | US20070173538 PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| 07/26/2007 | US20070173537 Indazole compound and pharmaceutical use thereof |
| 07/26/2007 | US20070173536 Crystalline forms of zolmitriptan |
| 07/26/2007 | US20070173535 Oxadiazoles having antiproliferative activity |
| 07/26/2007 | US20070173534 Pyridinic sulfonamide derivatives method of production and use thereof |
| 07/26/2007 | US20070173533 (2-fluorophenyl)-[3-hydroxy-3-(3-methoxyphenyl)-piperidine-1-yl]-methanone, used as analgesics and antiarrhythmia agents |
| 07/26/2007 | US20070173532 New Piperidine Antibiotics |
| 07/26/2007 | US20070173531 a non-steroidal sulphamate compound such as 6-Oxo-8,9,10,11-tetrahydro-7H-cyclohepta-[c][1]benzopyran-3-O-sulphamate, suitable for use as an inhibitor of estrone sulphatase, for the treatment of endocrine-dependent cancers and tumors, such as the breast and endometrium |
| 07/26/2007 | US20070173530 6-Aminoisoquinoline Compounds |
| 07/26/2007 | US20070173529 isoquinoline ring joined to a phenyl ring by a chemical group that is two bonds long and at least one cation or cationic group selected from sodium, potassium, ammonium, and tetraalkylammonium; Factor Xa inhibitor; anticoagulant; straightforward and economical synthesis |
| 07/26/2007 | US20070173528 Process for preparing solifenacin |
| 07/26/2007 | US20070173527 Histone deacetylase inhibitors |
| 07/26/2007 | US20070173526 Compounds and methods for treating dyslipidemia |
| 07/26/2007 | US20070173525 Receptor or non-receptor types; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, agents; retinal vascularization |
| 07/26/2007 | US20070173524 N-[2-(Indol-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(benzo[b]thiophen-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(indol-3-yl)ethyl]-S[(naphth-2-yl)methyl]-dithiocarbamate; anticarcinogenic agents; free of brassinin |
| 07/26/2007 | US20070173523 Reacting 17-carboxylic acid-3-oxo-4-azasteroid with carbonyl- or sulfinyl-diimidazole and amidating the product with an amime in the presence of a heterocyclic hydroxyl activator; avoids the use of expensive and moisture sensitive organomagnesium halide; preparing Finasteride and Dutasteride |
| 07/26/2007 | US20070173522 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6- tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 07/26/2007 | US20070173521 3-(1-acetylpiperidin-2-yl)-5-(1-cyclohexylethyl)-N-((2S,3R)-4-((S)-6-ethyl-2,2-spirocyclopentylchroman-4-ylamino)-3-hydroxy-1-phenylbutan-2-yl)benzamide; used for the treatment of Alzheimer's disease and conditions involving amyloid deposits on the brain |
| 07/26/2007 | US20070173520 stable dosage form of 5-methyl-pyridine-2-sulfonic acid [6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide, used for treatment of cardiovascular disorders |
| 07/26/2007 | US20070173519 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof |
| 07/26/2007 | US20070173518 Crystal of ticagrelor; G-protein coupled receptor antagonist, used for treating arterial thrombotic complications |
| 07/26/2007 | US20070173517 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides |
| 07/26/2007 | US20070173516 Pyrazine kinase inhibitors |
| 07/26/2007 | US20070173515 Delta opioid receptor agonist compounds |
| 07/26/2007 | US20070173514 Methods for suppressing an immune response or treating a proliferative disorder |
| 07/26/2007 | US20070173513 Imidazole compounds |
| 07/26/2007 | US20070173512 Imidazole compounds |
| 07/26/2007 | US20070173511 Cyclohexyl sulfonamide derivatives |
| 07/26/2007 | US20070173510 Imidazole compounds |
| 07/26/2007 | US20070173509 Imidazole compounds |
| 07/26/2007 | US20070173508 Tricyclic inhibitors of 5-lipoxygenase |
| 07/26/2007 | US20070173507 Dairyl-substituted five-membered heterocycle derivative |
| 07/26/2007 | US20070173506 Thiazole compounds and methods of use |
| 07/26/2007 | US20070173505 A2a adenosine receptor antagonists |
| 07/26/2007 | US20070173504 Calcium channel antagonists |
| 07/26/2007 | US20070173503 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives |
| 07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 07/26/2007 | US20070173501 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 07/26/2007 | US20070173500 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 07/26/2007 | US20070173499 Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |
| 07/26/2007 | US20070173497 11-Hydroxy-5h-pyrrolo[2,1-c][1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines |
| 07/26/2007 | US20070173496 rapid crystallization and seeding, step-wise drying; basification; solvent extraction; industrial scale |
| 07/26/2007 | US20070173495 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 07/26/2007 | US20070173494 Diaza heterocyclic sulfonamide derivatives and their uses |
| 07/26/2007 | US20070173493 1-Oxadibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders |
| 07/26/2007 | US20070173492 1,2-Diaza-dibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders |
| 07/26/2007 | US20070173491 Substituted lactams as inhibitors of Abeta protein production |
| 07/26/2007 | US20070173490 Novel solid forms of (4R)-1-[2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5- tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid |
| 07/26/2007 | US20070173489 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders |
| 07/26/2007 | US20070173488 Pyrazolothiazole Protein Kinase Modulators |
| 07/26/2007 | US20070173487 S1P receptor modulating compounds and use thereof |
| 07/26/2007 | US20070173486 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent; antidepressant; eating disorders, obesity, nicotine addiction, neuropathy, cognitive disorders, attention deficit disorder, stress, epilepsy, dementia, distonia, Alzheimer's |
| 07/26/2007 | US20070173485 Amminecyclohexanecarbonitriledichloroplatinum; platinum is capable of rapidly undergoing chelation with the Guanine or Adenine base of a DNA oligonucleotide at the 7 position; readily taken up by tumor cells |
| 07/26/2007 | US20070173484 Reacting risedronic acid with an organic amine base to form a salt and, in a mixture of water and solvent, exchanging the cation with sodium by reacting the salt with a sodium base. |
| 07/26/2007 | US20070173483 Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors |
| 07/26/2007 | US20070173482 Agents for preventing and treating disorders involving modulation of the RyR receptors |
| 07/26/2007 | US20070173481 Compositions and methods for preventing infection |
| 07/26/2007 | US20070173480 Formulations for mediating inflammatory bowel disorders |
| 07/26/2007 | US20070173479 Methods Using Sulodexide for the Treatment of Bladder Disease |
| 07/26/2007 | US20070173478 Compositions for the enhanced treatment of depression |
| 07/26/2007 | US20070173466 Methods of treating inflammatory diseases associated with bone destruction |
| 07/26/2007 | US20070173464 Oral ribavirin pharmaceutical compositions |
| 07/26/2007 | US20070173463 Method and composition for treating otitis media |
| 07/26/2007 | US20070173462 Treatment of diseases associated with the use of antibiotics |
| 07/26/2007 | US20070173461 Glycoside prodrug of 5- aminosalicylic acid |
| 07/26/2007 | US20070173460 Compositions comprising lignin and methods of making and using the same |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173448 Solution for removing cataracts via liquefracture |
| 07/26/2007 | US20070173434 Antidiabetic oxazolidinediones and thiazolidinediones |
| 07/26/2007 | US20070173051 Method and/or system for forming a thin film |
| 07/26/2007 | US20070172925 Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172528 Compositions containing vitamin E and saw palmetto |
| 07/26/2007 | US20070172525 Anti-diabetic combinations |
| 07/26/2007 | US20070172524 Process for preparing a solid pharmaceutical composition |